Skip to main content

Table 4 Use of antihypertensive medicines for the five main classes (defined daily dose [DDD]) and product type—generic or originator (proportion within class that is generic [%])—for single products in Ghana and Nigeria and combined countries plus difference between Nigeria and Ghana

From: Antihypertensive medicine use differs between Ghana and Nigeria

Class

Type

Ghana

Nigeria

Nigeria/Ghana

Use (DDD)

% generic

Use (DDD)

% generic

% generic

ARB

Generic

92,971

24.5

849,568

90.3

3.7

 

Originator

287,058

 

90,978

  
 

Total

380,029

 

940,546

  

CCB

Generic

184,622

59.4

787,031

97.9

1.6

 

Originator

126,023

 

16,814

  
 

Total

310,645

 

803,845

  

ACEi

Generic

24,534

18.9

501,055

97.4

5.2

 

Originator

105,249

 

13,367

  
 

Total

129,783

 

514,422

  

DU

Generic

6940

9.6

574,109

88.1

9.2

 

Originator

65,332

 

77,299

  
 

Total

72,272

 

651,408

  

BB

Generic

27,122

41.5

206,229

97.6

2.4

 

Originator

38,271

 

5093

  
 

Total

65,393

 

211,322

  
  1. ARB Angiotensin receptor blockers, CCB calcium channel blocker, ACEI angiotensin-converting enzyme inhibitor, BB beta-blocker, DU Diuretic